6:17 PM
 | 
Jun 27, 2013
 |  BC Extra  |  Financial News

Atlas, J&J venture arm back newco Rodin

Epigenetics company Rodin Therapeutics Inc. (Cambridge, Mass.) debuted on Thursday with undisclosed seed funding from Atlas Venture and Johnson & Johnson Development Corp. (JJDC), the venture arm of Johnson...

Read the full 135 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >